A gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence, according to a recent study by Vanderbilt-Ingram Cancer Center researchers. The findings, published in the March issue of Gastroenterology, could help personalize treatments for colon cancer – the second leading cause of cancer-related deaths in the United States – by …

Washington, Feb 27 : Researchers have suggested that a gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence.

A gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence, according to a recent study by Vanderbilt-Ingram Cancer Center researchers.The findings, published in the March issue of Gastroenterology, could help personalize treatments for colon cancer — the second leading cause of cancer-related deaths in the United States — by …

A gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence, according to a recent study by Vanderbilt-Ingram Cancer Center researchers.

Gene signature may help spot patients at colon cancer recurrence risk Daily News & Analysis WASHINGTON: Researchers have suggested that a gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon … and more

Researchers have suggested that a gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence.

Gene signature may improve colon cancer treatment Vanderbilt University News 2/26/2010 – A gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence, according to a … and more

( Vanderbilt University Medical Center ) A gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence, according to a recent study by Vanderbilt-Ingram Cancer Center researchers.The findings, published in the March issue of Gastroenterology, could help personalize treatments for colon cancer — the second leading cause of cancer …

A gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence, according to a recent study by Vanderbilt-Ingram Cancer Center researchers.

A gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence, according to a recent study. The findings could help personalize treatments for colon cancer — the second leading cause of cancer-related deaths in the United States — by identifying patients most likely to benefit from chemotherapy.